B. Riley & Co. Acts as Exclusive Financial Advisor to Cardiogenesis Corp. in Its Sale to CryoLife Inc.

B. Riley & Co., LLC (B. Riley) www.brileyco.com, a full service broker dealer providing research and trading to institutional clients and investment banking services, today announced that it has served as the exclusive financial advisor to Cardiogenesis Corporation (OTCQB: CGCP) in its sale to CryoLife, Inc. (NYSE: CRY).

The transaction, closed and announced on May 17, 2011, is valued at approximately $21.7 million.

B. Riley Managing Directors Michael Lowell and Timothy McQuay led the banking team in this transaction with Irvine, California-based Cardiogenesis, a leading developer of surgical products used in the treatment of patients with refractory angina resulting from diffuse coronary artery disease. Atlanta, Georgia-based CryoLife is a leader in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries throughout the U.S. and Canada.

“The B. Riley team did an excellent job in representing Cardiogenesis,” said Cardiogenesis Chairman Paul McCormick. “Without B. Riley’s exceptional efforts, we would not have completed such a favorable transaction for our shareholders.”

In addition to completing this transaction, B. Riley is expanding its banking efforts in, and coverage of the healthcare sector. It recently announced the hiring of Senior Research Analyst Laura McGuigan, CFA, to cover the medical technology sector.

ABOUT B. RILEY & CO.

B. Riley & Co. is a leading independent investment bank which provides a full array of corporate finance, research, sales, trading and otcqx dad services to corporate, institutional and high net worth individual clients. Investment banking services include merger and acquisitions advisory to public and private middle market companies, initial and secondary public offerings and institutional private placements. Its Corporate Governance Advisory Services Group is engaged by both companies and investors to help maximize value for shareholders.The firm is recognized for its distinguished Equity Research. Founded in 1997, B. Riley is headquartered in Los Angeles and maintains offices in Newport Beach, San Francisco, Philadelphia and New York. It is a member of FINRA and SIPC. For more information, please visit www.brileyco.com.www.brileyco.com.

Key Words:

Exclusive Financial Advisor
Merger & Acquisitions
The Deal M&A
Investment Bank
Institutional Private Placements
Equity Recapitalizations
Registered Direct Offering
Shelf Registration Offering
Medical Technologies
Healthcare
Cardiac Treatments
Coronary Artery Disease
Equity Sales & Trading
Small Cap Stocks